Fauna Bio

Fauna Bio is an AI-driven drug discovery company that leverages data from 100 million years of evolved disease resistance in mammals. Using its exclusive biobank of genetic data and its in-house platform, Convergence™, the company replicates how extreme animal models resist disease to create new drugs for humans. Fauna Bio uses AI to identify targets from its biobank that are highly conserved across species, including humans, and then uses computational tools to find similar pathways in humans activated by drug compounds.

Fauna Bio is an AI-driven drug discovery company that leverages data from 100 million years of evolved disease resistance in mammals. The company uses its exclusive biobank of genetic data along with its in-house platform, Convergence™, to replicate how extreme animal models resist disease, aiming to create new drugs that do the same for humans. Fauna Bio uses AI to identify targets from its biobank that are highly conserved across species, including humans, and then uses cutting-edge computational tools to find similar pathways in humans activated by drug compounds. The company is led by co-founder and CEO Ashley Zehnder and founder and CSO Katie Grabek.

First company to combine studying diverse species, natural genetic resistance, and AI-driven drug discovery to create new therapeutic opportunities.

1. 1Fauna Biofaunabio.com
2. 2About Usfaunabio.com